An investigation for investors in Eyenovia, Inc. (NASDAQ: EYEN) shares over potential securities laws violations by Eyenovia, Inc. was announced.

San Diego, CA -- (SBWire) -- 06/18/2018 --An investigation was announced over potential securities laws violations by Eyenovia, Inc. in connection with certain financial statements.

Investors who purchased shares of Eyenovia, Inc. (NASDAQ: EYEN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Eyenovia, Inc. (NASDAQ: EYEN) concerning whether a series of statements by Eyenovia, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

New York based Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. Eyenovia, Inc. went public in January 2018. Since then shares of Eyenovia, Inc. (NASDAQ: EYEN) declined from $10.74 per share on January 25, 2018 to as low as $7.63 per share on May 25, 2018.

On June 8, 2018, NASDAQ: EYEN shares closed at $8.39 per share.

Those who purchased shares of Eyenovia, Inc. (NASDAQ: EYEN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com